Munch; Jan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Munch; Jan.The latest application filed is for "new molecular tweezers against neurological disorders and viral infections".

Company Profile

0.9.9

Munch; Jan - Neu-Ulm DE
Munch; Jan - Hannover DE
Munch; Jan - Ulm DE
Munch; Jan - Erlangen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
New Molecular Tweezers Against Neurological Disorders And Viral Infections App 20210122771 - Bitan; Gal ; et al.	2021-04-29
Peptides with antagonistic activities against natural CXCR4 Grant 10,294,272 - Forssmann , et al.	2019-05-21
Peptides With Antagonistic Activities Against Natural Cxcr4 App 20160122389 - Forssmann; Wolf-Georg ; et al.	2016-05-05
CXC chemokine receptor 4 (CXCR4) antagonistic polypeptide Grant 9,045,563 - Forssmann , et al. June 2, 2	2015-06-02
Viral infection enhancing peptide Grant 8,652,483 - Munch , et al. February 18, 2	2014-02-18
Cxc Chemokine Receptor 4 (cxcr4) Antagonistic Polypeptide App 20130029902 - Forssmann; Wolf-Georg ; et al.	2013-01-31
Viral Infection Enhancing Peptide App 20120122177 - MUNCH; Jan ; et al.	2012-05-17
Peptides for the treatment of herpes virus infections Grant 7,741,287 - Forssmann , et al. June 22, 2	2010-06-22
Peptides and their use for the treatment of HIV infections Grant 7,655,629 - Adermann , et al. February 2, 2	2010-02-02
Human Semen Enhancer of Viral Infection Peptides (SEVI) and Their Use App 20090191206 - Standker; Ludger ; et al.	2009-07-30
Peptides for the Treatment of Herpes Virus Infections App 20080312144 - Forssmann; Wolf-Georg ; et al.	2008-12-18
Oligomeric peptides and their use for the treatment of hiv infections App 20070123465 - Adermann; Knut ; et al.	2007-05-31
Peptides and their use for the treatment of hiv infections App 20070072805 - Andermann; Knut ; et al.	2007-03-29
Peptide (VIRIP) which inhibits a circulating virus in humans and the use thereof Grant 7,037,896 - Kirchhoff , et al. May 2, 2	2006-05-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.